TELA Bio (TELA) Total Debt Growth (3y) (2021 - 2026)
TELA Bio (TELA) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -13.48% |
| 10 | TELA Bio | 36.75 Mn | 6.32 Mn | 13.94 Mn | 11.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.73% |
| Mar 31, 2026 | 11.72% |
| Dec 31, 2025 | 11.72% |
| Sep 30, 2025 | 1.43% |
| Jun 30, 2025 | 1.47% |
| Mar 31, 2025 | 9.23% |
| Dec 31, 2024 | 9.30% |
| Sep 30, 2024 | 9.37% |
| Jun 30, 2024 | 9.43% |
| Mar 31, 2024 | 9.49% |
| Dec 31, 2023 | 9.54% |
| Sep 30, 2023 | 9.58% |
| Jun 30, 2023 | 9.62% |
| Mar 31, 2023 | 9.66% |
| Dec 31, 2022 | 9.69% |
| Sep 30, 2022 | 9.72% |
| Dec 31, 2021 | 1.93% |